Preclinical development of ZED8, an 89Zr immuno-PET reagent for monitoring tumor CD8 status in patients undergoing cancer immunotherapy

Author:

Ogasawara Annie,Kiefer James R.,Gill Herman,Chiang Eugene,Sriraman Shravan,Ferl Gregory Z.,Ziai James,Bohorquez Sandra Sanabria,Guelman Sebastian,Wang Xiangdan,Yang Jihong,Phan Minh Michael,Nguyen Van,Chung Shan,Yu Christine,Tinianow Jeff,Waaijer Stijn Jan Hein,De Crespigny Alex,Marik Jan,Boswell C. Andrew,Zabka Tanja,Staflin Karin,Williams Simon-Peter

Publisher

Springer Science and Business Media LLC

Subject

Radiology, Nuclear Medicine and imaging,General Medicine,Radiology, Nuclear Medicine and imaging,General Medicine

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Structure, function, and immunomodulation of the CD8 co-receptor;Frontiers in Immunology;2024-08-26

2. The role of CD8 PET imaging in guiding cancer immunotherapy;Frontiers in Immunology;2024-07-12

3. Development of an 18F-labeled anti-human CD8 VHH for same-day immunoPET imaging;European Journal of Nuclear Medicine and Molecular Imaging;2022-11-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3